The Open UniversitySkip to content
 

Clinical immunotherapy trials in Alzheimer's disease

Hawkes, Cheryl A. and McLaurin, JoAnne (2008). Clinical immunotherapy trials in Alzheimer's disease. Drug Discovery Today: Therapeutic Strategies, 5(3) pp. 177–183.

DOI (Digital Object Identifier) Link: https://doi.org/10.1016/j.ddstr.2008.09.004
Google Scholar: Look up in Google Scholar

Abstract

The success of active and passive anti-Aβ immunotherapies in both preventing and clearing parenchymal amyloid in transgenic mouse models, led to the initiation of an active anti-Aβ vaccination trial in human patients with mild-to-moderate AD, which was prematurely halted in 2002 because of inflammatory complications. Since then, Aβ immunotherapy strategies have been refined to produce antibodies that specifically target neurotoxic amyloid species without eliciting adverse side effects. More than seven major clinical trials are currently ongoing to test the safety and efficacy of the new generation of active and passive anti-Aβ vaccines. Results from these trials will provide valuable information about the effectiveness of immunotherapy in slowing and/or reversing cognitive impairments and will provide direction for the future of antiAβ immunization as an interventional or prophylactic clinical tool.

Item Type: Journal Item
Copyright Holders: 2008 Elsevier Ltd
ISSN: 1740-6773
Academic Unit/School: Faculty of Science, Technology, Engineering and Mathematics (STEM) > Life, Health and Chemical Sciences
Faculty of Science, Technology, Engineering and Mathematics (STEM)
Related URLs:
Item ID: 44098
Depositing User: Cheryl Hawkes
Date Deposited: 07 Sep 2015 09:44
Last Modified: 07 Dec 2018 10:34
URI: http://oro.open.ac.uk/id/eprint/44098
Share this page:

Metrics

Altmetrics from Altmetric

Citations from Dimensions

Actions (login may be required)

Policies | Disclaimer

© The Open University   contact the OU